ask="1.75"
ask_size="17200"
average_daily_volume="1597450"
bid="1.35"
bid_size="5000"
book_value="1.36"
change="+0.04"
change_from_200_day_moving_average="0.04"
change_from_50_day_moving_average="0.09"
change_from_52_week_high="-5.39"
change_From_52_week_low="0.55"
change_in_percent="+3.01%"
close="1.37"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.60"
ebitda="-29.80M"
eps_estimate_current_year="-1.48"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.21"
ex_dividend_date="N/A"
float_shares="13985000"
high="1.38"
high_52_weeks="6.76"
last_trade_date="3/6/2017"
last_trade_price="1.37"
last_trade_size="200"
last_trade_time="4:00pm"
low="1.31"
low_52_weeks="0.82"
market_capitalization="27.00M"
moving_average_200_day="1.33"
moving_average_50_day="1.28"
name="Marinus Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="3.33"
open="1.34"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+3.24%"
percent_change_from_50_day_moving_average="+6.86%"
percent_change_from_52_week_high="-79.73%"
percent_change_from_52_week_low="+66.81%"
previous_close="1.33"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.98"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="19705000"
short_ratio="0.88"
stock_exchange="NGM"
symbol="MRNS"
volume="466795"
weeks_range_52="0.82 - 6.76"
